SERPINE1 and Alzheimer disease: The discrepancy in which Aβ form was reduced could be attributed to the use of different AD mouse models for these experiments, the nature of the PAI-1 inhibitors (i.e., different binding sites, efficacy, and off-target effects), or different timelines of PAI-1 inhibitor treatment.